Jun Guo

4.6k total citations
118 papers, 3.2k citations indexed

About

Jun Guo is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Jun Guo has authored 118 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 26 papers in Neurology and 26 papers in Immunology. Recurrent topics in Jun Guo's work include Peripheral Neuropathies and Disorders (17 papers), Immunotherapy and Immune Responses (14 papers) and Multiple Sclerosis Research Studies (13 papers). Jun Guo is often cited by papers focused on Peripheral Neuropathies and Disorders (17 papers), Immunotherapy and Immune Responses (14 papers) and Multiple Sclerosis Research Studies (13 papers). Jun Guo collaborates with scholars based in China, United States and France. Jun Guo's co-authors include Xuetao Cao, Taoyong Chen, Mingjin Yang, Huazhang An, Minghui Zhang, Viswanath P. Kurup, Chaofeng Han, Zhenhong Guo, Yizhi Yu and Jianli Wang and has published in prestigious journals such as The Lancet, Blood and Nature Immunology.

In The Last Decade

Jun Guo

107 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Guo China 31 1.2k 1.1k 449 338 326 118 3.2k
Tomoh Matsumiya Japan 30 1.4k 1.2× 1.2k 1.1× 535 1.2× 381 1.1× 281 0.9× 126 3.0k
Andrea Fattorossi Italy 33 1.0k 0.8× 1.1k 1.0× 740 1.6× 384 1.1× 230 0.7× 141 3.5k
Fang Liu China 31 857 0.7× 915 0.8× 409 0.9× 512 1.5× 231 0.7× 187 2.9k
Xuebin Qin United States 33 1.4k 1.1× 1.1k 1.0× 225 0.5× 413 1.2× 129 0.4× 93 3.6k
Eric Smith United States 26 975 0.8× 1.8k 1.6× 1.2k 2.7× 486 1.4× 223 0.7× 46 3.9k
Chunyan Liu China 32 1.4k 1.2× 1.2k 1.1× 787 1.8× 309 0.9× 386 1.2× 183 3.6k
Navneet K. Dhillon United States 31 491 0.4× 1.4k 1.3× 659 1.5× 443 1.3× 285 0.9× 93 3.6k
Satoshi Fujii Japan 35 673 0.6× 1.9k 1.7× 444 1.0× 604 1.8× 797 2.4× 149 4.5k
Hans‐Pietro Eugster Switzerland 35 1.9k 1.6× 1.0k 0.9× 584 1.3× 373 1.1× 339 1.0× 58 3.9k
Hans A.R. Bluyssen Poland 33 1.4k 1.1× 1.2k 1.0× 927 2.1× 244 0.7× 381 1.2× 72 2.8k

Countries citing papers authored by Jun Guo

Since Specialization
Citations

This map shows the geographic impact of Jun Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Guo more than expected).

Fields of papers citing papers by Jun Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Guo. The network helps show where Jun Guo may publish in the future.

Co-authorship network of co-authors of Jun Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Guo. A scholar is included among the top collaborators of Jun Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Guo. Jun Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Xu, Jun, Sihan Zhou, Yuanyuan Xu, et al.. (2025). Identification of cardiotoxic targets of doxorubicin via network toxicology and development of exosome-based delivery system for osteosarcoma therapy. International Immunopharmacology. 161. 115011–115011. 1 indexed citations
4.
Xie, Jian, et al.. (2024). Analysis of influencing factors and construction of nomogram prediction model of postoperative kinesiophobia in patients undergoing total knee arthroplasty. Pakistan Journal of Medical Sciences. 40(11). 2550–2557. 1 indexed citations
5.
6.
Yin, Yanyan, Jun Guo, Shuo Zhang, et al.. (2024). Research progress and prospect of tumor nanovaccine combination therapy strategy. Chinese Chemical Letters. 36(10). 110771–110771.
7.
Zhao, Cong, Jiarui Lu, Yu Han, et al.. (2023). Efficacy and safety of repeated low-dose rituximab therapy in relapsing-remitting multiple sclerosis: A retrospective case series study. Multiple Sclerosis and Related Disorders. 70. 104518–104518. 2 indexed citations
8.
Zhang, Wenting, Lingling Yao, Jiarui Lu, et al.. (2023). Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases. Vaccine X. 15. 100388–100388. 1 indexed citations
9.
Zhao, Cong, Pei Liu, Jiaqi Ding, et al.. (2022). Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review. Brain Sciences. 12(8). 995–995. 5 indexed citations
10.
Ren, Kaixi, Aili Yang, Jiarui Lu, et al.. (2021). Association between serum low‐density neutrophils and acute‐onset and recurrent Guillain–Barré syndrome. Brain and Behavior. 12(1). e2456–e2456. 6 indexed citations
11.
Ma, Yanyan, et al.. (2021). Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles. Neurological Sciences. 42(8). 3485–3490. 9 indexed citations
12.
Zhao, Sijia, Kai Zhang, Kaixi Ren, et al.. (2021). Clinical features, treatment and prognosis of MuSK antibody-associated myasthenia gravis in Northwest China: a single-centre retrospective cohort study. BMC Neurology. 21(1). 428–428. 10 indexed citations
13.
Ding, Jiaqi, Sijia Zhao, Kaixi Ren, et al.. (2020). Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China. BMC Neurology. 20(1). 238–238. 17 indexed citations
14.
Shu, Yaqing, Jun Guo, Xueying Ma, et al.. (2020). Anti‐N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations. European Journal of Neurology. 28(2). 595–601. 18 indexed citations
15.
Liu, Pei, Kaixi Ren, Jiaqi Ding, et al.. (2020). Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report. Therapeutic Advances in Neurological Disorders. 13. 1279191030–1279191030. 5 indexed citations
16.
Guo, Jun, Xiao Yu, Xin Lü, et al.. (2019). Empowering therapeutic antibodies with IFN-α for cancer immunotherapy. PLoS ONE. 14(8). e0219829–e0219829. 20 indexed citations
17.
Yan, Yan, Jun Guo, Weijia Jiang, et al.. (2012). A preliminary study on Norovirus variant for GII.4 in Guiyang regions. Zhonghua weishengwuxue he mianyixue zazhi. 32(7). 606–609. 1 indexed citations
18.
Guo, Jun. (2009). Clinical Analysis of 23 Cases of Severe Hand,Foot and Mouth Disease with Neurogenic Pulmonary Edema in Fuyang City. Testowy IndexCopernicus. 1 indexed citations
19.
Guo, Jun. (2004). Discussion on Highway Construction in West Development Influencing Society and Ecological Environment.. 1 indexed citations
20.
Luo, Xiaoling, Yizhi Yu, Anmin Liang, et al.. (2004). Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.. PubMed. 1(3). 199–204. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026